Skip to main content
Fig. 1 | Clinical and Translational Allergy

Fig. 1

From: Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study

Fig. 1

Severity of icatibant-treated attacks by body mass index (BMI). P values comparing severity of attacks (very mild/mild/moderate versus severe/very severe): P = 0.136 for normal versus overweight; P = 0.627 for normal versus obese; P = 0.109 for overweight versus obese. Results excluding data from the two reinjection outliers are presented in Additional file 1: Figure S1. n = number of attacks. Very mild = very mild interference with daily activities; mild = mild interference with daily activities; moderate = moderate interference with daily activities and no other countermeasures required; severe = severe interference with daily activities and with or without other countermeasures; very severe = very severe interference with daily activities and other countermeasures required

Back to article page

Clinical and Translational Allergy

ISSN: 2045-7022

Contact us